Global Vitamin K3 Market was valued at USD XX Billion in the year 2021. Global Vitamin K3 Market is further estimated to grow at a CAGR of XX% from 2022 to 2030 it will reach USD XX Billion by the year 2030. The North America region holds the highest market share in 2021 and the Asia Pacific is considered as the fastest growing market in the forecasted period. At a country level, US, China are projected to grow strongly in the coming years due to increasing density of population and funding through Research and Development.
The Global Vitamin K3 Report 2022-2030 covers market opportunities and challenges, key market regulations’ information, analysis of new products from the market players and key market trends, market share analysis for key players, supply chain and value chain analysis, product and Material trends, pricing analysis, emerging applications, technologies and major recent developments. This information has also been provided for the major country markets in these regions. Market shares, size and growth potential are assessed for these major country markets. Market opportunities, challenges, government regulations, market share analysis by major competitors, recent major market developments (product launches, M&A, partnerships, etc.) and other information have been covered for the major country markets listed in this section.
On the basis of Grade, the market is divided as Feed Grade and Pharmaceutical Grade. In which Feed Grade for the largest market share due to increasing demand in future market trends. Regional breakdown and deep analysis of each of the aforesaid segments is included for North America, Europe, Asia-Pacific, and ROW.
Market player analysis of major companies such as Mianyang Vanatta Chemical, Hubei Zhenhua Chemical, Shandong Huasheng Chemical, Chongqing Minfeng Chemical, Yunnan Luliang Peace Technology, Brother Enterprises Holding, OXYVIT, Dirox S.A., Peace Chemical, and Zhenhua Chemical.

1 INTRODUCTION
1.1 OBJECTIVES
1.2 RESEARCH METHODOLOGY
1.2.1 SECONDARY DATA
1.2.2 PRIMARY DATA
1.2.3 MARKET SIZE ESTIMATION
1.2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
1.3 STAKEHOLDERS
1.4 RESEARCH ASSUMPTIONS
1.5 LIMITATION
2 EXECUTIVE SUMMARY
3 MARKET OUTLOOK
3.1 INTRODUCTION
3.2 OPPORTUNITIES MATRIX
3.3 MARKET CHALLENGES
3.4 MARKET SHARE ANALYSIS
3.5 VALUE CHAIN ANALYSIS
3.6 DEMAND SIDE ANALYSIS
3.7 SUPPLY SIDE ANALYSIS
3.8 PORTER’S FIVE FORCES MODEL
3.8.1 DEGREE OF COMPETITION
3.8.2 BARGAINING POWER OF BUYERS
3.8.3 BARGAINING POWER OF SUPPLIERS
3.8.4 THREAT FROM SUBSTITUTES
3.8.5 THREAT FROM NEW ENTRANTS
4 INDUSTRY TRENDS
4.1 PRODUCT LIFE CYCLE
4.2 NEW MARKET ENTRY STRATEGY
4.3 PESTEL ANALYSIS
4.4 PRICING ANALYSIS
4.5 TRADE DATA
4.6 TECHNOLOGICAL OVERVIEW
4.7 FUTURE OUTLOOK MARKET TRENDS
4.8 MACRO-ECONOMIC VARIABLES (DEPENDENT AND INDEPENDENT VARIABLES)
4.9 MULTIFACTOR BASED SENSITIVITY ANALYSIS
4.10 REGRESSION MATRIX
4.11 COVID-19 IMPACT ANALYSES
4.12 GE MATRIX
5 VITAMIN K3 GRADE ANALYSIS
5.1 INTRODUCTION
5.2 HISTORICAL MARKET GRADE ANALYSIS, 2016-2020
5.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
5.4 Y-O-Y GROWTH TREND ANALYSIS
5.5 FEED GRADE
5.6 PHARMACEUTICAL GRADE
6 VITAMIN K3 ROUTE OF ADMINISTRATION ANALYSIS
6.1 INTRODUCTION
6.2 HISTORICAL MARKET ROUTE OF ADMINISTRATION ANALYSIS, 2016-2020
6.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
6.4 Y-O-Y GROWTH TREND ANALYSIS
6.5 ORAL
6.6 TOPICAL
6.7 PARENTERAL
7 VITAMIN K3 MODE OF CONSUMPTION ANALYSIS
7.1 INTRODUCTION
7.2 HISTORICAL MARKET MODE OF CONSUMPTION ANALYSIS, 2016-2020
7.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
7.4 Y-O-Y GROWTH TREND ANALYSIS
7.5 PILLS
7.6 POWDERS
7.7 CREAMS
7.8 LIQUIDS
8 VITAMIN K3 END USER ANALYSIS
8.1 INTRODUCTION
8.2 HISTORICAL MARKET END USER ANALYSIS, 2016-2020
8.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
8.4 Y-O-Y GROWTH TREND ANALYSIS
8.5 FEED
8.6 MEDICAL
9 VITAMIN K3 MARKET APPLICATION ANALYSIS
9.1 INTRODUCTION
9.2 HISTORICAL MARKET APPLICATION ANALYSIS, 2016-2020
9.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
9.4 Y-O-Y GROWTH TREND ANALYSIS
9.5 OSTEOPOROSIS
9.6 VITAMIN-K DEPENDENT CLOTTING FACTOR DEFICIENCY [VKCFD]
9.7 DERMAL APPLICATIONS
9.8 PROTHROMBIN DEFICIENCY
9.9 VITAMIN K DEFICIENCY BLEEDING [VKDB]
10 GLOBAL VITAMIN K3 REGIONAL ANALYSIS
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 NORTH AMERICA HISTORICAL MARKET COUNTRY ANALYSIS, 2016-2020
10.2.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
10.2.3 Y-O-Y GROWTH TREND ANALYSIS
10.2.3.1 U.S.
10.2.3.2 Canada
10.2.3.3 Mexico
10.3 ASIA-PACIFIC
10.3.1 APAC HISTORICAL MARKET COUNTRY ANALYSIS, 2016-2020
10.3.2 Y-O-Y GROWTH TREND ANALYSIS
10.3.2.1 China
10.3.2.2 Japan
10.3.2.3 Korea
10.3.2.4 India
10.3.2.5 Southeast Asia
10.4 MIDDLE EAST AND AFRICA
10.4.1 MIDDLE EAST AND AFRICA HISTORICAL MARKET COUNTRY ANALYSIS, 2016-2020
10.4.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
10.4.3 Y-O-Y GROWTH TREND ANALYSIS
10.4.3.1 Saudi Arabia
10.4.3.2 UAE
10.4.3.3 Egypt
10.4.3.4 Nigeria
10.4.3.5 South Africa
10.5 EUROPE
10.5.1 EUROPE HISTORICAL MARKET COUNTRY ANALYSIS, 2016-2020
10.5.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
10.5.3 Y-O-Y GROWTH TREND ANALYSIS
10.5.3.1 Germany
10.5.3.2 France
10.5.3.3 UK
10.5.3.4 Russia
10.5.3.5 Italy
10.6 LATIN AMERICA
10.6.1 LATIN AMERICA HISTORICAL MARKET COUNTRY ANALYSIS, 2016-2020
10.6.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
10.6.3 Y-O-Y GROWTH TREND ANALYSIS
10.6.3.1 Brazil
10.6.3.2 Argentina
10.6.3.3 Columbia
11 MARKET PLAYERS
11.1 MIANYANG VANATTA CHEMICAL,
11.1.1 BUSINESS OVERVIEW:
11.1.2 PRODUCT PORTFOLIO
11.1.3 RECENT DEVELOPMENTS
11.1.4 SWOT ANALYSIS:
11.2 HUBEI ZHENHUA CHEMICAL,
11.3 SHANDONG HUASHENG CHEMICAL,
11.4 CHONGQING MINFENG CHEMICAL,
11.5 YUNNAN LULIANG PEACE TECHNOLOGY,
11.6 BROTHER ENTERPRISES HOLDING,
11.7 OXYVIT,
11.8 DIROX S.A.,
11.9 PEACE CHEMICAL,
11.10 ZHENHUA CHEMICAL
12 ABOUT US

TABLE 1 VITAMIN K3 REGIONAL ANALYSIS, 2021–2030 (USD MILLION)
TABLE 2 GLOBAL VITAMIN K3 MARKET, 2021–2030, (USD MILLION)
TABLE 3 VITAMIN K3 CURRENT AND FUTURE REGIONAL ANALYSIS, 2021–2030 (USD MILLION)
TABLE 4 GLOBAL VITAMIN K3 HISTORICAL MARKET GRADE ANALYSIS, 2016-2020, (USD MILLION)
TABLE 5 VITAMIN K3 CURRENT AND FUTURE GRADE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 6 GLOBAL VITAMIN K3 HISTORICAL MARKET ROUTE OF ADMINISTRATION ANALYSIS, 2016-2020, (USD MILLION)
TABLE 7 VITAMIN K3 CURRENT AND FUTURE ROUTE OF ADMINISTRATION ANALYSIS, 2021–2030 (USD MILLION)
TABLE 8 GLOBAL VITAMIN K3 HISTORICAL MARKET MODE OF CONSUMPTION ANALYSIS, 2016-2020, (USD MILLION)
TABLE 9 VITAMIN K3 CURRENT AND FUTURE MODE OF CONSUMPTION ANALYSIS, 2021–2030 (USD MILLION)
TABLE 10 GLOBAL VITAMIN K3 HISTORICAL MARKET END USER ANALYSIS, 2016-2020, (USD MILLION)
TABLE 11 VITAMIN K3 CURRENT AND FUTURE END USER ANALYSIS, 2021–2030 (USD MILLION)
TABLE 12 GLOBAL VITAMIN K3 HISTORICAL MARKET APPLICATION ANALYSIS, 2016-2020, (USD MILLION)
TABLE 13 VITAMIN K3 CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030 (USD MILLION)
TABLE 14 NORTH AMERICA VITAMIN K3 HISTORICAL MARKET ANALYSIS, 2016-2020, (USD MILLION)
TABLE 15 NORTH AMERICA VITAMIN K3 CURRENT AND FUTURE GRADE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 16 NORTH AMERICA VITAMIN K3 CURRENT AND FUTURE ROUTE OF ADMINISTRATION ANALYSIS, 2021–2030 (USD MILLION)
TABLE 17 NORTH AMERICA VITAMIN K3 CURRENT AND FUTURE MODE OF CONSUMPTION ANALYSIS, 2021–2030 (USD MILLION)
TABLE 18 NORTH AMERICA VITAMIN K3 CURRENT AND FUTURE END USER ANALYSIS, 2021–2030 (USD MILLION)
TABLE 19 NORTH AMERICA VITAMIN K3 CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030 (USD MILLION)
TABLE 20 U.S. VITAMIN K3 CURRENT AND FUTURE GRADE ANALYSIS, 2016–2021
TABLE 21 U.S. VITAMIN K3 CURRENT AND FUTURE GRADE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 22 U.S. VITAMIN K3 CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 23 CANADA VITAMIN K3 CURRENT AND FUTURE GRADE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 24 CANADA VITAMIN K3 CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 25 MEXICO VITAMIN K3 CURRENT AND FUTURE GRADE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 26 MEXICO VITAMIN K3 CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 27 APAC VITAMIN K3 HISTORICAL MARKET ANALYSIS, 2016-2020, (USD MILLION)
TABLE 28 ASIA-PACIFIC VITAMIN K3 CURRENT AND FUTURE GRADE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 29 ASIA-PACIFIC VITAMIN K3 CURRENT AND FUTURE ROUTE OF ADMINISTRATION ANALYSIS, 2021–2030 (USD MILLION)
TABLE 30 ASIA-PACIFIC VITAMIN K3 CURRENT AND FUTURE MODE OF CONSUMPTION ANALYSIS, 2021–2030 (USD MILLION)
TABLE 31 ASIA-PACIFIC VITAMIN K3 CURRENT AND FUTURE END USER ANALYSIS, 2021–2030 (USD MILLION)
TABLE 32 ASIA-PACIFIC VITAMIN K3 CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030 (USD MILLION)
TABLE 33 CHINA VITAMIN K3 CURRENT AND FUTURE GRADE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 34 CHINA VITAMIN K3 CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 35 JAPAN VITAMIN K3 CURRENT AND FUTURE GRADE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 36 JAPAN VITAMIN K3 CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 37 KOREA VITAMIN K3 CURRENT AND FUTURE GRADE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 38 KOREA VITAMIN K3 CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 39 INDIA VITAMIN K3 CURRENT AND FUTURE GRADE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 40 INDIA VITAMIN K3 CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 41 SOUTHEAST ASIA VITAMIN K3 CURRENT AND FUTURE GRADE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 42 SOUTHEAST ASIA VITAMIN K3 CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 43 MIDDLE EAST AND AFRICA VITAMIN K3 HISTORICAL MARKET ANALYSIS, 2016-2020, (USD MILLION)
TABLE 44 MIDDLE EAST AND AFRICA VITAMIN K3 CURRENT AND FUTURE GRADE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 45 MIDDLE EAST AND AFRICA VITAMIN K3 CURRENT AND FUTURE ROUTE OF ADMINISTRATION ANALYSIS, 2021–2030 (USD MILLION)
TABLE 46 MIDDLE EAST AND AFRICA VITAMIN K3 CURRENT AND FUTURE MODE OF CONSUMPTION ANALYSIS, 2021–2030 (USD MILLION)
TABLE 47 MIDDLE EAST AND AFRICA VITAMIN K3 CURRENT AND FUTURE END USER ANALYSIS, 2021–2030 (USD MILLION)
TABLE 48 MIDDLE EAST AND AFRICA VITAMIN K3 CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030 (USD MILLION)
TABLE 49 SAUDI ARABIA VITAMIN K3 CURRENT AND FUTURE GRADE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 50 SAUDI ARABIA VITAMIN K3 CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 51 UAE VITAMIN K3 CURRENT AND FUTURE GRADE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 52 UAE VITAMIN K3 CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 53 EGYPT VITAMIN K3 CURRENT AND FUTURE GRADE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 54 EGYPT VITAMIN K3 CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 55 NIGERIA VITAMIN K3 CURRENT AND FUTURE GRADE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 56 NIGERIA VITAMIN K3 CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 57 SOUTH AFRICA VITAMIN K3 CURRENT AND FUTURE GRADE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 58 SOUTH AFRICA VITAMIN K3 CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 59 EUROPE VITAMIN K3 HISTORICAL MARKET ANALYSIS, 2016-2020, (USD MILLION)
TABLE 60 EUROPE VITAMIN K3 CURRENT AND FUTURE GRADE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 61 EUROPE VITAMIN K3 CURRENT AND FUTURE ROUTE OF ADMINISTRATION ANALYSIS, 2021–2030 (USD MILLION)
TABLE 62 EUROPE VITAMIN K3 CURRENT AND FUTURE MODE OF CONSUMPTION ANALYSIS, 2021–2030 (USD MILLION)
TABLE 63 EUROPE VITAMIN K3 CURRENT AND FUTURE END USER ANALYSIS, 2021–2030 (USD MILLION)
TABLE 64 EUROPE VITAMIN K3 CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030 (USD MILLION)
TABLE 65 GERMANY VITAMIN K3 CURRENT AND FUTURE GRADE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 66 GERMANY VITAMIN K3 CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 67 FRANCE VITAMIN K3 CURRENT AND FUTURE GRADE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 68 FRANCE VITAMIN K3 CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 69 UK VITAMIN K3 CURRENT AND FUTURE GRADE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 70 UK VITAMIN K3 CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 71 RUSSIA VITAMIN K3 CURRENT AND FUTURE GRADE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 72 RUSSIA VITAMIN K3 CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 73 ITALY VITAMIN K3 CURRENT AND FUTURE GRADE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 74 ITALY VITAMIN K3 CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 75 LATIN AMERICA VITAMIN K3 HISTORICAL MARKET ANALYSIS, 2016-2020, (USD MILLION)
TABLE 76 LATIN AMERICA VITAMIN K3 CURRENT AND FUTURE GRADE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 77 LATIN AMERICA VITAMIN K3 CURRENT AND FUTURE ROUTE OF ADMINISTRATION ANALYSIS, 2021–2030 (USD MILLION)
TABLE 78 LATIN AMERICA VITAMIN K3 CURRENT AND FUTURE MODE OF CONSUMPTION ANALYSIS, 2021–2030 (USD MILLION)
TABLE 79 LATIN AMERICA VITAMIN K3 CURRENT AND FUTURE END USER ANALYSIS, 2021–2030 (USD MILLION)
TABLE 80 LATIN AMERICA VITAMIN K3 CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030 (USD MILLION)
TABLE 81 BRAZIL VITAMIN K3 CURRENT AND FUTURE GRADE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 82 BRAZIL VITAMIN K3 CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 83 ARGENTINA VITAMIN K3 CURRENT AND FUTURE GRADE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 84 ARGENTINA VITAMIN K3 CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 85 COLUMBIA VITAMIN K3 CURRENT AND FUTURE GRADE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 86 COLUMBIA VITAMIN K3 CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 1 GLOBAL VITAMIN K3 MARKET, 2021–2030, (USD MILLION)
FIGURE 2 RESEARCH METHODOLOGY
FIGURE 3 GLOBAL VITAMIN K3 CURRENT AND FUTURE MARKET, 2021–2030, (USD MILLION)
FIGURE 4 GLOBAL VITAMIN K3 CURRENT AND FUTURE MARKET, 2021–2030, (USD MILLION)
FIGURE 5 MARKET OVERVIEW
FIGURE 6 SWOT ANALYSIS
FIGURE 7 MARKET SHARE ANALYSIS
FIGURE 8 SUPPLY CHAIN ANALYSIS
FIGURE 9 PORTER’S FIVE FORCES ANALYSIS
FIGURE 10 VITAMIN K3 GRADE ANALYSIS
FIGURE 11 GLOBAL VITAMIN K3 CURRENT AND FUTURE MARKET GRADE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 12 VITAMIN K3 ROUTE OF ADMINISTRATION ANALYSIS
FIGURE 13 GLOBAL VITAMIN K3 CURRENT AND FUTURE MARKET ROUTE OF ADMINISTRATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 14 VITAMIN K3 MODE OF CONSUMPTION ANALYSIS
FIGURE 15 GLOBAL VITAMIN K3 CURRENT AND FUTURE MARKET MODE OF CONSUMPTION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 16 VITAMIN K3 END USER ANALYSIS
FIGURE 17 GLOBAL VITAMIN K3 CURRENT AND FUTURE MARKET END USER ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 18 VITAMIN K3 APPLICATION ANALYSIS
FIGURE 19 GLOBAL VITAMIN K3 CURRENT AND FUTURE MARKET APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 20 GLOBAL VITAMIN K3 CURRENT AND FUTURE MARKET VOLUME SHARE REGIONAL ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 21 MARKET OVERVIEW, REGIONAL ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 22 MARKET SHARE BY COUNTRY
FIGURE 23 NORTH AMERICA VITAMIN K3 CURRENT AND FUTURE GRADE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 24 NORTH AMERICA VITAMIN K3 CURRENT AND FUTURE ROUTE OF ADMINISTRATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 25 NORTH AMERICA VITAMIN K3 CURRENT AND FUTURE MODE OF CONSUMPTION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 26 NORTH AMERICA VITAMIN K3 CURRENT AND FUTURE END USER ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 27 NORTH AMERICA VITAMIN K3 CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 28 U.S. VITAMIN K3 CURRENT AND FUTURE GRADE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 29 U.S. VITAMIN K3 CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 30 CANADA VITAMIN K3 CURRENT AND FUTURE GRADE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 31 CANADA VITAMIN K3 CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 32 MEXICO VITAMIN K3 CURRENT AND FUTURE GRADE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 33 MEXICO VITAMIN K3 CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 34 MARKET SHARE BY COUNTRY
FIGURE 35 APAC VITAMIN K3 CURRENT AND FUTURE GRADE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 36 APAC VITAMIN K3 CURRENT AND FUTURE ROUTE OF ADMINISTRATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 37 APAC VITAMIN K3 CURRENT AND FUTURE MODE OF CONSUMPTION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 38 APAC VITAMIN K3 CURRENT AND FUTURE END USER ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 39 APAC VITAMIN K3 CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 40 CHINA VITAMIN K3 CURRENT AND FUTURE GRADE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 41 CHINA VITAMIN K3 CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 42 JAPAN VITAMIN K3 CURRENT AND FUTURE GRADE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 43 JAPAN VITAMIN K3 CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 44 KOREA VITAMIN K3 CURRENT AND FUTURE GRADE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 45 KOREA VITAMIN K3 CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 46 INDIA VITAMIN K3 CURRENT AND FUTURE GRADE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 47 INDIA VITAMIN K3 CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 48 SOUTHEAST ASIA VITAMIN K3 CURRENT AND FUTURE GRADE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 49 SOUTHEAST ASIA VITAMIN K3 CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 50 MARKET SHARE BY COUNTRY
FIGURE 51 MIDDLE EAST AND AFRICA VITAMIN K3 CURRENT AND FUTURE GRADE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 52 MIDDLE EAST AND AFRICA VITAMIN K3 CURRENT AND FUTURE ROUTE OF ADMINISTRATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 53 MIDDLE EAST AND AFRICA VITAMIN K3 CURRENT AND FUTURE MODE OF CONSUMPTION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 54 MIDDLE EAST AND AFRICA VITAMIN K3 CURRENT AND FUTURE END USER ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 55 MIDDLE EAST AND AFRICA VITAMIN K3 CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 56 SAUDI ARABIA VITAMIN K3 CURRENT AND FUTURE GRADE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 57 SAUDI ARABIA VITAMIN K3 CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 58 UAE VITAMIN K3 CURRENT AND FUTURE GRADE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 59 UAE VITAMIN K3 CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 60 EGYPT VITAMIN K3 CURRENT AND FUTURE GRADE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 61 EGYPT VITAMIN K3 CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 62 NIGERIA VITAMIN K3 CURRENT AND FUTURE GRADE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 63 NIGERIA VITAMIN K3 CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 64 SOUTH AFRICA VITAMIN K3 CURRENT AND FUTURE GRADE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 65 SOUTH AFRICA VITAMIN K3 CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 66 MARKET SHARE BY COUNTRY
FIGURE 67 EUROPE VITAMIN K3 CURRENT AND FUTURE GRADE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 68 EUROPE VITAMIN K3 CURRENT AND FUTURE ROUTE OF ADMINISTRATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 69 EUROPE VITAMIN K3 CURRENT AND FUTURE MODE OF CONSUMPTION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 70 EUROPE VITAMIN K3 CURRENT AND FUTURE END USER ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 71 EUROPE VITAMIN K3 CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 72 GERMANY VITAMIN K3 CURRENT AND FUTURE GRADE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 73 GERMANY VITAMIN K3 CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 74 FRANCE VITAMIN K3 CURRENT AND FUTURE GRADE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 75 FRANCE VITAMIN K3 CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 76 UK VITAMIN K3 CURRENT AND FUTURE GRADE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 77 UK VITAMIN K3 CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 78 RUSSIA VITAMIN K3 CURRENT AND FUTURE GRADE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 79 RUSSIA VITAMIN K3 CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 80 ITALY VITAMIN K3 CURRENT AND FUTURE GRADE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 81 ITALY VITAMIN K3 CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 82 MARKET SHARE BY COUNTRY
FIGURE 83 LATIN AMERICA VITAMIN K3 CURRENT AND FUTURE GRADE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 84 LATIN AMERICA VITAMIN K3 CURRENT AND FUTURE ROUTE OF ADMINISTRATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 85 LATIN AMERICA VITAMIN K3 CURRENT AND FUTURE MODE OF CONSUMPTION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 86 LATIN AMERICA VITAMIN K3 CURRENT AND FUTURE END USER ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 87 LATIN AMERICA VITAMIN K3 CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 88 BRAZIL VITAMIN K3 CURRENT AND FUTURE GRADE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 89 BRAZIL VITAMIN K3 CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 90 ARGENTINA VITAMIN K3 CURRENT AND FUTURE GRADE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 91 ARGENTINA VITAMIN K3 CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 92 COLUMBIA VITAMIN K3 CURRENT AND FUTURE GRADE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 93 COLUMBIA VITAMIN K3 CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 94 FINANCIAL OVERVIEW: